Abbott India Limited has reported standalone financial results for the period ended March 31, 2024.
Lupin appoints Jeffrey Kindler, Alfonso `Chito` Zulueta as Independent directors
Pathology company Dr Lal PathLabs Limited on May 10 reported 52 percent jump in consolidated net profit at Rs 85 crore for the quarter ended 31 March, 2024. The company had reported a net profit of Rs 56 crore in the year-ago period.
Pharma major Cipla on May 10 reported a consolidated net profit of Rs 939 crore for the quarter ended March 2024, making a 78 percent spike over last year's Rs 525.6 crore.
OJSP has launched Sudhamukti ayurvedic medicine, a breakthrough in diabetes management. Developed under the visionary leadership of Prassant Kumar, founder of OJSP, Sudhamukti ayurvedic medicine represent a culmination of his personal journey with diabetes and a quest for effective, natural solutions.
Soaring temperatures in many parts of India are fuelling demand for medications that manage chronic conditions. This includes medications for high blood pressure (antihypertensives), cholesterol (lipid-lowering drugs), and blood clotting (platelet aggregation inhibitors).
Alembic Pharmaceuticals Limited has reported consolidated financial results for the period ended March 31, 2024.
Medico Remedies has reported standalone financial results for the period ended March 31, 2024.
On World Thalassemia Day, Samyak Ghoderao, a 10-year-old survivor of thalassemia major from Nashik, reunited with Dr Priyatesh Dwivedi, marking a heart-rending moment in his journey of triumph against the disease. Samyak's story is one of resilience and medical breakthroughs, underscored by a successful haploidentical (half-match) stem cell transplant performed at HCG Manavata Cancer Centre (HCGMCC). Diagnosed with thalassemia major at the tender age of six months, Samyak's life depended on regular blood transfusions. The absence of a full match donor posed a significant challenge until his family sought help from Dr Dwivedi, renowned for his expertise in haematology and stem cell transplants.
Home-based cancer care is one of the major shifts that has gained momentum after the pandemic disruption. Patients today have a much wider range of treatment choices including hospital care and home-based hospital grade disease management through remote patient monitoring and telemedicine, informed Vaibhav Tewari, CEO & co-founder, Portea Medical.